TAE bags $40M to take targeted radiotherapy mainstream | FierceBiotech
Mar 26, 2018 @ 9:47

TAE Life Sciences has raised $40 million to eliminate the main bottleneck to widespread use of boron neutron capture therapy (BNCT). The startup, a spinoff from a nuclear fusion company, is working on a neutron source designed to take BNCT out of nuclear research reactors and into hospitals.

Sourced through Scoop.it from: www.fiercebiotech.com

Leave a Reply